Understanding The Art And Science Of CRO Selection
Industry Standard Research (ISR) has been collecting data on CRO selection and performance for nearly 15 years. We’ve watched the industry grow, service offerings expand, and providers consolidate and spin off. Through it all, we have been surveying industry decision makers to keep a finger on the pulse of how CRO selections are made and how providers have performed for their recent customers. This e-book examines the rationale behind how CROs are selected, why they are retained, and why sponsors opt for one provider or outsourcing model versus another.
“Company Size And PPAs – Peeling The Layers Of Phase 2/3 Service Provider Selection” (pp. 6-7) examines Phase 2 and Phase 3 outsourcing through the lens of organizations with and without benefit of a preferred provider agreement (PPA). While a preferred provider has been thoroughly vetted and has a contract in place, very few small companies, per recent CRO benchmarking results, have PPAs in place for Phase 2/3 services. So how do these segments proceed with provider selection when they don’t have that luxury?
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.